Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05822193 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 19, 2025 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Mar 1, 2024 to Jul 1, 2025
    • Study completion date: Mar 1, 2024 to Jul 31, 2025
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 1, 2023 to Jul 21, 2023
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a national retrospective cohort study with internet-based recruitment which intends to enroll 1,694 adult patients with COVID-19 diagnosis during the SARS-CoV-2 omicron wave in Brazil. Participants with confirmed symptomatic COVID-19 after january 2022 will be evaluated in order to assess incidence, potential risk factors and impact of post COVID-19 condition according to the WHO definition on health-related quality of life and other relevant patient-centered outcomes.
Trial Details
NCT Number NCT05822193
Lead Sponsor Inova Medical
Collaborators: Merck Sharp & Dohme LLC
Conditions
(from sponsor)		 Post-Acute COVID-19 Syndrome
Related terms Post-Acute COVID-19 Syndrome
Enrollment 1,694 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov